Bumetanide continuous infusions in critically ill pediatric patients.
Katie M McCallister1, Rebecca F Chhim, Mario Briceno-Medina
11Department of Clinical Pharmacy, University of Tennessee Health Science Center, Memphis, TN. 2Le Bonheur Children's Hospital, Memphis, TN. 3Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN.
Summary
Continuous bumetanide infusions effectively achieved negative fluid balance in most critically ill children. This study indicates bumetanide is a safe and effective loop diuretic for pediatric intensive care unit patients.
Area of Science:
- Pediatric Critical Care Medicine
- Pharmacology
- Nephrology
Background:
- Limited data exist regarding the efficacy and safety of continuous bumetanide infusions in pediatric patients.
- Fluid overload is a common complication in critically ill children, necessitating effective diuretic strategies.
- Understanding optimal dosing and outcomes for bumetanide continuous infusions is crucial for managing fluid balance in this population.
Purpose of the Study:
- To evaluate the use of bumetanide continuous infusions in critically ill pediatric patients.
- To assess the effectiveness of bumetanide in achieving negative fluid balance.
- To determine the safety profile of bumetanide continuous infusions in this patient group.
Main Methods:
- Retrospective chart review of 95 critically ill pediatric patients (≤18 years) receiving bumetanide continuous infusions.
- Dosing evaluated by rate (μg/kg/hr) and duration (days).
- Efficacy assessed by negative fluid balance at 12, 24, and 48 hours; safety evaluated by adverse drug reactions.
Main Results:
- Mean bumetanide dose was 5.7 ± 2.2 μg/kg/hr, with a median duration of 3.3 days.
- 76% of patients achieved negative fluid balance by 48 hours.
- 54% of patients reached negative fluid balance within the first 12 hours.
Conclusions:
- A bumetanide dose of 5.7 μg/kg/hr was effective in achieving negative fluid balance in the majority of critically ill pediatric patients.
- Bumetanide appears to be a safe loop diuretic for continuous infusion in critically ill pediatric patients at the studied doses.
- Continuous bumetanide infusion is a viable option for fluid management in pediatric intensive care settings.
Related Concept Videos
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
398
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
398
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
391
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
01:30Continuous Renal Replacement Therapy
2.1K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
2.1K
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
367
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
367
01:29Drug Dosing: Infants and Children
929
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
929
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
513
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
513